Disclaimer :

The Competition DG makes the information provided by the notifying parties in section 1.2 of Form CO available to the public in order to increase transparency. This information has been prepared by the notifying parties under their sole responsibility, and its content in no way prejudges the view the Commission may take of the planned operation. Nor can the Commission be held responsible for any incorrect or misleading information contained therein.

SECTION 1.2

On 28 July 2011, the Commission received the notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) 139/2004 by which the undertakings FUJIFILM Holdings Corporation ("FH") and Mitsubishi Corporation ("MC") will acquire, within the meaning of Article 3(1)(b) of the Regulation, joint control of FUJIFILM Diosynth Biotechnologies UK Limited ("FDBUK") and FUJIFILM Dyosynth Biotechnologies U.S.A., Inc. ("FDBUS"). FDBUK and FDBUS are currently wholly owned by FH. Post-transaction, MC will hold 20% of the shares and FH will hold 80% of the shares in each of FDBUK and FDBUS.

The business activities of the undertakings concerned are:

(i) FH: manufacturing and marketing of imaging, information and document systems;

(ii) MC: general trading activities in various industries, including energy, metals, machinery, chemicals, food and general merchandise; and

(iii) FDBUK and FDBUS: biologics contract manufacturing services.

In view of the absence of any horizontal overlaps or vertical effects in the EU, the Notifying Parties submit that the Proposed Transaction will not give rise to competitive concerns.